You are looking for

As the old saying goes, making predictions can be difficult – especially about the future. If you need evidence of this, think how you might have answered the question ‘Where do you see yourself in five years’ time?’ if you had been asked in 2016.  But while the pandemic has delivered a harsh lesson in […]

Bringing innovative medical technology to patients around the world is a priority for the medtech industry. This task often relies on a wide network of third-party intermediaries and distributors. While third parties provide valuable local knowledge, logistics and skills, it is important to appreciate that everyone working on behalf of medtech companies is bound by […]

Almost 12 months after the WHO declared a global COVID-19 pandemic, people with rare diseases can reflect on a turbulent year – even if there are some positive lessons to be learned in how services are delivered. While the pandemic continues, most reflections on the crisis come to a common conclusion: everyone suffered, but not […]

For people living with chronic obstructive pulmonary disease (COPD), a long-term lung illness, COVID-19 is having a major impact. The pandemic has disrupted traditional models of care and put vulnerable patients at risk. Keeping patients out of hospital – by reducing scheduled visits and avoiding emergency admissions – has become the top priority.  A silver […]

We’re at the heart of the global response to COVID-19, a powerful reminder of our mission to enable our customers to make the world healthier,cleaner and safer. What’s driving us every day is the feeling that there is a meaning to our work over and beyond the reward of the paycheck. What’s compelling now is […]

For decades, companies in the medtech and pharma sectors have delivered healthcare innovations separately – collaboration has been limited. However, we know that this is not how patients experience healthcare. In the real world, diagnostics, devices, medicines, vaccines and digital tools combine to keep people healthy and to treat those who are unwell.  This reality […]

Healthcare should put patients at the heart of decision-making, while delivering benefits for society as efficiently as possible. This, I believe, was clear before the pandemic. However, the additional strain under which our systems must operate at present, as well as additional demands for resources, make the case for value-based healthcare (VBHC) stronger than ever […]

This is the second in a two-part series. Read part one. The link between clinical and social aspects of COVID-19 raises the question of what type of data are needed to manage the COVID-19 surge and better absorb shocks that may be caused by future pandemics.  We believe clinical patient level data are essential given […]

The power of diagnostics information (VODI) to public health and society was a topic of keen interest even before the COVID-19 outbreak. The pandemic offers us fresh lessons on how health systems can harness this value.  Many of us will recall one of the earliest recommendation from the Director General of the WHO during the […]